Related Experiment Video
Updated: Oct 24, 2025

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
A circular RNA, circSMARCA5, inhibits prostate cancer proliferative, migrative, and invasive capabilities via the
Xin Xie1, Fu-Kang Sun1, Xin Huang1
1Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China.
Abstract:
SMARCA5 (circSMARCA5) is involved in the occurrence of different cancers, but its role in prostate cancer carcinogenesis and metastatic transformation remains elusive. Thus, we evaluated the circSMARCA5 functional relevance in prostate cancer and its associated molecular mechanism. First, circSMARCA5 expression and function in this cancer were evaluated. To determine the miR-181b-5p/miR-17-3p target and clarify how circSMARCA5 regulates the miR-181b-5p-TIMP3 and miR-17-3p-TIMP3 axis, RNA immunoprecipitation, biotin-coupled microRNA capture, luciferase reporter, Western blot, and quantitative real-time PCR assays were employed. In primary and metastatic prostate cancer tissues, circSMARCA5 was significantly downregulated compared with normal controls. Functionally, circSMARCA5 exhibited a suppressive effect on prostate cancer cells' metastasis and growth. At the molecular level, circSMARCA5 could affect the tissue inhibitor of metalloproteinases 3 (TIMP3) expression through miR-181b-5p or miR-17-3p interactions. Moreover, lysine acetyltransferase 5 (KAT5) induced circSMARCA5 biogenesis and regulated the miR-181b-5p-TIMP3 and miR-17-3p-TIMP3 axis. These results suggested that targeting circSMARCA5-miR-181b-5p-TIMP3 and circSMARCA5-miR-17-3p-TIMP3 axis might be a novel therapeutic strategy for prostate cancer.
Insights
Circular RNA SMARCA5 (circSMARCA5) is downregulated in prostate cancer, suppressing metastasis and growth. It regulates TIMP3 expression via miR-181b-5p/miR-17-3p, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The role of SMARCA5 (circSMARCA5) in prostate cancer progression and metastasis is not well understood.
- circSMARCA5 is implicated in various cancers, but its specific function in prostate cancer remains elusive.
Purpose of the Study:
- To investigate the functional significance of circSMARCA5 in prostate cancer.
- To elucidate the molecular mechanisms underlying circSMARCA5's role in prostate cancer carcinogenesis and metastasis.
Main Methods:
- Quantitative real-time PCR and Western blot assays were used to assess circSMARCA5 and TIMP3 expression.
- RNA immunoprecipitation, biotin-coupled microRNA capture, and luciferase reporter assays were employed to determine molecular interactions.
- Prostate cancer tissues and cell lines were utilized for functional and mechanistic studies.
Main Results:
- circSMARCA5 expression was significantly downregulated in primary and metastatic prostate cancer tissues compared to normal controls.
- circSMARCA5 demonstrated a suppressive effect on prostate cancer cell growth and metastasis.
- circSMARCA5 regulates Tissue Inhibitor of Metalloproteinases 3 (TIMP3) expression through interactions with miR-181b-5p and miR-17-3p.
- Lysine acetyltransferase 5 (KAT5) was found to induce circSMARCA5 biogenesis and modulate the miR-181b-5p-TIMP3/miR-17-3p-TIMP3 axis.
Conclusions:
- circSMARCA5 acts as a tumor suppressor in prostate cancer by inhibiting metastasis and growth.
- The circSMARCA5-miR-181b-5p-TIMP3 and circSMARCA5-miR-17-3p-TIMP3 axes represent novel molecular pathways in prostate cancer.
- Targeting these circSMARCA5-mediated pathways could offer a new therapeutic strategy for prostate cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Experimental RNAi
piRNA - Piwi-interacting RNAs

